| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥37.09B | ¥35.27B | +5.1% |
| Cost of Sales | ¥11.22B | ¥10.62B | +5.7% |
| Gross Profit | ¥25.86B | ¥24.66B | +4.9% |
| SG&A Expenses | ¥23.25B | ¥24.50B | -5.1% |
| Operating Income | ¥2.62B | ¥160M | +1536.2% |
| Non-operating Income | ¥255M | ¥253M | +0.8% |
| Non-operating Expenses | ¥730M | ¥445M | +64.0% |
| Ordinary Income | ¥2.14B | ¥-31M | +7016.1% |
| Profit Before Tax | ¥1.88B | ¥-768M | +344.9% |
| Income Tax Expense | ¥1.14B | ¥20M | +5610.0% |
| Net Income | ¥739M | ¥-788M | +193.8% |
| Net Income Attributable to Owners | ¥-380M | ¥-1.05B | +63.7% |
| Total Comprehensive Income | ¥296M | ¥-908M | +132.6% |
| Interest Expense | ¥339M | ¥341M | -0.6% |
| Basic EPS | ¥-2.79 | ¥-7.85 | +64.5% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥30.26B | ¥30.86B | ¥-607M |
| Cash and Deposits | ¥19.07B | ¥20.63B | ¥-1.56B |
| Accounts Receivable | ¥4.41B | ¥4.26B | +¥148M |
| Inventories | ¥2.62B | ¥1.84B | +¥773M |
| Non-current Assets | ¥39.45B | ¥42.39B | ¥-2.94B |
| Item | Value |
|---|---|
| Net Profit Margin | -1.0% |
| Gross Profit Margin | 69.7% |
| Current Ratio | 248.8% |
| Quick Ratio | 227.3% |
| Debt-to-Equity Ratio | 1.14x |
| Interest Coverage Ratio | 7.72x |
| Effective Tax Rate | 60.7% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +5.1% |
| Operating Income YoY Change | +963.6% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 136.60M shares |
| Treasury Stock | 21K shares |
| Average Shares Outstanding | 136.47M shares |
| Book Value Per Share | ¥238.09 |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥0.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| Biofuel | ¥716M | ¥-177M |
| HealthCare | ¥34.56B | ¥4.35B |
| Others | ¥1.82B | ¥-381M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥50.00B |
| Operating Income Forecast | ¥3.20B |
| Dividend Per Share Forecast | ¥0.00 |
| Property, Plant & Equipment | ¥5.85B | ¥6.05B | ¥-200M |
| Intangible Assets | ¥31.67B | ¥33.56B | ¥-1.90B |
| Goodwill | ¥11.53B | ¥12.23B | ¥-704M |
| Investment Securities | ¥1.24B | ¥748M | +¥487M |
| Total Assets | ¥69.71B | ¥73.26B | ¥-3.54B |
| Current Liabilities | ¥12.16B | ¥12.81B | ¥-651M |
| Accounts Payable | ¥1.54B | ¥1.47B | +¥78M |
| Short-term Loans | ¥3.80B | ¥4.14B | ¥-341M |
| Non-current Liabilities | ¥25.03B | ¥28.33B | ¥-3.30B |
| Long-term Loans | ¥12.91B | ¥15.96B | ¥-3.05B |
| Total Liabilities | ¥37.19B | ¥41.14B | ¥-3.95B |
| Total Equity | ¥32.52B | ¥32.11B | +¥405M |
| Capital Stock | ¥16.37B | ¥16.33B | +¥42M |
| Capital Surplus | ¥16.92B | ¥16.88B | +¥42M |
| Retained Earnings | ¥-2.64B | ¥-2.26B | ¥-380M |
| Treasury Stock | ¥-34M | ¥-34M | ¥0 |
| Owners' Equity | ¥30.96B | ¥31.70B | ¥-737M |
| Working Capital | ¥18.10B | - | - |